- Home
- WPP vs CORT Comparison
WPP vs CORT Comparison
Compare WPP & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WPP
- CORT
- Stock Information
- Founded
- WPP 1985
- CORT 1998
- Country
- WPP United Kingdom
- CORT United States
- Employees
- WPP N/A
- CORT N/A
- Industry
- WPP Advertising
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- WPP Consumer Discretionary
- CORT Health Care
- Exchange
- WPP Nasdaq
- CORT Nasdaq
- Market Cap
- WPP 5.9B
- CORT 7.6B
- IPO Year
- WPP N/A
- CORT N/A
- Fundamental
- Price
- WPP $25.85
- CORT $78.28
- Analyst Decision
- WPP Sell
- CORT Strong Buy
- Analyst Count
- WPP 1
- CORT 4
- Target Price
- WPP N/A
- CORT $139.00
- AVG Volume (30 Days)
- WPP 345.6K
- CORT 675.5K
- Earning Date
- WPP 08-07-2025
- CORT 10-29-2025
- Dividend Yield
- WPP 9.78%
- CORT N/A
- EPS Growth
- WPP 86.47
- CORT N/A
- EPS
- WPP 0.47
- CORT 1.11
- Revenue
- WPP $19,423,208,660.00
- CORT $716,080,000.00
- Revenue This Year
- WPP N/A
- CORT $30.62
- Revenue Next Year
- WPP N/A
- CORT $37.68
- P/E Ratio
- WPP $56.21
- CORT $67.23
- Revenue Growth
- WPP N/A
- CORT 25.71
- 52 Week Low
- WPP $24.28
- CORT $38.68
- 52 Week High
- WPP $57.37
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- WPP 38.03
- CORT 66.26
- Support Level
- WPP $26.03
- CORT $69.03
- Resistance Level
- WPP $26.91
- CORT $74.79
- Average True Range (ATR)
- WPP 0.48
- CORT 2.84
- MACD
- WPP 0.01
- CORT 0.63
- Stochastic Oscillator
- WPP 9.89
- CORT 96.02
About WPP WPP plc
Headquartered in the United Kingdom, WPP is the world's largest ad holding company based on annual revenue. Its services, which include traditional and digital advertising, public relations, and consulting, are provided worldwide, with over 70% of its revenue coming from more developed regions such as North America, the UK, and Western Europe. WPP is the largest media buying entity in the world.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.